Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal hourly PIEB bolus volume of ropivacaine + dexmedetomidine for epidural labor analgesia
ChiCTR2600134218Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine and dexmedetomidine in labor pain, sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Effective analgesia. Planned start May 2026; status: not yet recruiting.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2600134218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134218.